MED12 related disorders.

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• The Mediator complex, including MED12, is crucial for RNA polymerase II transcription.
• MED12 regulates cell growth, differentiation, and gene silencing, and suppresses Sonic hedgehog signaling.
• MED12 mutations are implicated in several X-linked intellectual disability syndromes.

Purpose of the Study:

• To compare and contrast four distinct clinical conditions associated with MED12 mutations.
• To explore the genotype-phenotype correlations in MED12-related disorders.
• To aid in the identification and diagnosis of intellectual disability syndromes linked to MED12.

Main Methods:

• Review of existing literature on MED12 mutations and associated syndromes.
• Comparison of clinical features across four specific conditions: Opitz-Kaveggia (FG) syndrome, Lujan syndrome, Ohdo syndrome (OSMKB), and a novel frameshift mutation case.
• Analysis of genetic findings, including a frameshift mutation affecting MED12 protein truncation.

Main Results:

• Four distinct clinical conditions associated with MED12 mutations are presented: Opitz-Kaveggia (FG) syndrome, Lujan syndrome, Ohdo syndrome (OSMKB), and a novel family with a c.5898insC frameshift mutation.
• The novel mutation resulted in affected female carriers and MED12 protein truncation, distinguishing it from the other three syndromes.
• Overlapping clinical features are observed across these MED12-related disorders.

Conclusions:

• MED12 mutations contribute to a spectrum of X-linked intellectual disability syndromes.
• Understanding these MED12-related disorders is essential for accurate diagnosis and genetic counseling.
• Exome sequencing is expected to reveal more MED12 mutations in patients with intellectual disability and dysmorphic features.